Boule Diagnostics AB (publ)
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a BOUL.ST research report →
Companywww.boule.com
Boule Diagnostics AB (publ), a diagnostics company, develops, manufactures, and markets instruments and consumable products for blood diagnostics. The company provides hematology analyzers, reagents, blood controls and calibrators, and reagents rotors, as well as cleaning products under the Swelab, Medonic, and Quintus brands; and veterinary hematology and clinical chemistry analyzer and diagnostics systems under the Exigo brand. It sells its products directly in Sweden and the United States, as well as through distributors internationally.
- CEO
- Torben Nielsen
- IPO
- 2011
- Employees
- 200
- HQ
- Spånga, SE
Price Chart
Valuation
- Market Cap
- $131.26M
- P/E
- -16.83
- P/S
- 0.27
- P/B
- 0.77
- EV/EBITDA
- 12.63
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 42.31%
- Op Margin
- 4.39%
- Net Margin
- -1.63%
- ROE
- -4.66%
- ROIC
- -23.16%
Growth & Income
- Revenue
- $489.70M · -12.33%
- Net Income
- $-3,800,000 · 98.30%
- EPS
- $-0.10 · 98.26%
- Op Income
- $25.20M
- FCF YoY
- 93.13%
Performance & Tape
- 52W High
- $10.60
- 52W Low
- $3.14
- 50D MA
- $3.76
- 200D MA
- $4.94
- Beta
- 0.17
- Avg Volume
- 41.39K
Get TickerSpark's AI analysis on BOUL.ST
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our BOUL.ST Coverage
We haven't published any research on BOUL.ST yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate BOUL.ST Report →